Familial micronodular adrenocortical disease, cushing syndrome, and mutations of the gene encoding phosphodiesterase 11A4 (PDE11A)

American Journal of Surgical Pathology

Volumn 34, Issue 4, 2010, Pages 547-555

  Carney, J Aidan ^a   Gaillard, Rolf C ^b   Bertherat, Jérôme ^c   Stratakis, Constantine A ^d  

^a MAYO CLINIC   (United States)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^c Institut Cochin   (France)

^d EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

Cushing syndrome; Micronodular adrenal hyperplasia; PDE11A mutation; Primary pigmented nodular adrenocortical disease; PRKAR1A mutation

Indexed keywords

PDE11A PROTEIN, HUMAN; PHOSPHODIESTERASE;

ADRENAL CORTEX; ADRENAL CORTEX DISEASE; ADRENAL GLAND; ADRENALECTOMY; ADULT; ARTICLE; CHILD; CUSHING SYNDROME; FAMILY HEALTH; FEMALE; GENETIC PREDISPOSITION; GENETICS; HUMAN; METABOLISM; ORGAN SIZE; PATHOLOGY;

ADRENAL CORTEX; ADRENAL CORTEX DISEASES; ADRENAL GLANDS; ADRENALECTOMY; ADULT; CHILD; CUSHING SYNDROME; FAMILY HEALTH; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; ORGAN SIZE; PHOSPHORIC DIESTER HYDROLASES; YOUNG ADULT;

EID: 77950204638     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e3181d31f49     Document Type: Article

References (24)

1. Bimapaki EI, Nesterova M, Stratakis CA. Abnormalities of cAMP signaling are present in adrenocortical lesions associated with ACTH-independent Cushing syndrome despite the absence of mutations in known genes. Eur J Endocrinol. 2009;161:153-161.
2. Carney JA, Lloyd RV. Adrenal gland. In: Mills SE, ed. Histology for Pathologists. Philadelphia: Lippincott Williams and Wilkins; 2007:1167-1188.
3. Carney JA, Gordon H, Carpenter PC, et al. The complex of myxomas, spotty pigmentation and endocrine overactivity. Medicine. 1995;64:270-283.
4. Casey M, Vaughan CJ, He J, et al. Mutations in the protein kinase A R1a regulatory subunit cause familial cardiac myxomas and Carney complex. J Clin Invest. 2000;106:R31-R38.
5. Cushing H. The basophil adenomas of the pituitary body and their clinical manifestations (pituitary basophilism). Bull Johns Hopkins Hosp. 1932;1:137-195.
6. Groussin L, Kirschner LS, Vincent-Dejean C, et al. Molecular analysis of the cyclic AMP-dependent protein kinase A (PKA) regulatory subunit 1A (PRKAR1A) gene in patients with Carney complex and primary pigmented nodular adrenocortical disease (PPNAD) reveals novel mutations and clues for pathophysiology: augmented PKA signaling is associated with adrenal tumorigenesis in PPNAD. Am J Hum Genet. 2002;71:1433-1442.
7. Horvath A, Bertherat J, Groussin L, et al. Mutations and polymorphisms in the gene encoding regulatory subunit type 1-alpha of protein kinase A (PRKAR1A): an update. Hum Mutat. In press.
8. Horvath A, Boikos S, Giatzakis C, et al. A genome-wide screen identifies the gene encoding phosphodiesterase 11A4 (PDE11A4) mutated in patients with a novel form of adrenal hyperplasia. Nature Genet. 2006;38:794-800.
9. Horvath A, Giatzakis C, Tsang K, et al. A cAMP-specific phosphodiesterase (PDE8B) that is mutated in adrenal hyperplasia is expressed widely in human and mouse tissues: a novel PDE8B isoform in human adrenal cortex. Eur J Hum Genet. 2008;16: 1245-1253.
10. Horvath A, Mericq V, Stratakis CA. Mutation in PDE8B, a cyclic AMP-specific phosphodiesterase in adrenal hyperplasia. New Engl J Med. 2009;358:750-752.
11. Isidori AM, Kaltas GA, Pozza C, et al. The ectopic adrenocortico-trophin syndrome: clinical features, diagnosis, management and long-term follow-up. J Clin Endocrinol Metab. 2006;91:371-377.
12. Kirk JM, Brain CE, Carson DJ, et al. Cushing's syndrome caused by nodular adrenal hyperplasia in children with McCune-Albright syndrome. J Pediatr. 1999;134:789-792.
13. Kirschner LS, Carney JA, Pack S, et al. Mutations of the gene encoding the protein kinase A type 1-a regulatory subunit in patients with the Carney complex. Nature Genet. 2000;26:89-92.
14. Kirschner LS, Sandrini F, Monbo J, et al. Genetic heterogeneity and spectrum of mutations of the PRKAR1A gene in patients with the Carney complex. Hum Mol Genet. 2000;9:3037-3046.
15. Lack EE, Travis WD, Oertel JE. Adrenal cortical nodules, hyperplasia, and hyperfunction. In: Lack EE, ed. Pathology of the Adrenal Glands. New York: Churchill Livingstone; 1990:75-113.
16. Nussbaum RL, McInnes RR, Willard HT. Thompson and Thompson Genetics in Medicine. Philadelphia, PA: Saunders, Elsevier; 2007.
17. Online Mendelian Inheritance in Man, OMIM #160980. McKusick-Nathans Institute for Genetic Medicine, Johns Hopkins University (Baltimore, MD) and National Center for Biotechnology Information, National Library of Medicine (Bethesda, MD); 2009. Updated 4-20-2009.
18. Page DL, DeLellis RA, Hough Jr. Tumors of the Adrenal (Atlas of Tumor Pathology, Second Series, Fascicle 23). Washington, DC: Armed Forces Institute of Pathology; 1986:56-80.
19. Ruder HJ, Loriaux DL, Lipsett MB. Severe osteopenia in young adults associated with Cushing's syndrome due to micronodular adrenal disease. J Clin Endocrinol Metab. 1974;39:1138-1147.
20. Schweizer-Cagianut M, Salomon F, Hedinger Chr E. Primary adrenocortical nodular dysplasia with Cushing's syndrome and cardiac myxomas. A peculiar familial disease. Virchows Arch (Pathol Anat). 1982;397:187-192.
21. Shenoy BV, Carpenter PC, Carney JA. Bilateral primary pigmented nodular adrenocortical disease. Am J Surg Pathol. 1984;8:335-344.
22. Stratakis CA, Kirschner LS, Carney JA. Clinical and molecular features of the Carney complex: diagnostic criteria and recommendations for patient evaluation. J Clin Endocrinol Metab. 2001;86: 4041-4046.
23. Weinstein LS, Schenker A, Gejman PV, et al. Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. N Engl J Med. 1991;325:1688-1695.
24. Weiss GM, Nelson RL, O'Neill BP, et al. Use of adrenal biopsy in diagnosing adrenomyeloleukodystrophy. Arch Neurol. 1980;37: 634-636.